Looks like this might be another opportunity for Rce to show its effectiveness? I am assuming it would be effective here.
https://www.dailymail.co.uk/health/article-11658263/US-investigating-two-cases-super-strength-gonorrhea-strain.html
Ann: Anti-Infective Research Unit est. at Murdoch Children's, page-39
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.010(1.75%) |
Mkt cap ! $118.3M | |||
| Open | High | Low | Value | Volume |
| 59.3¢ | 60.0¢ | 57.0¢ | $118.9K | 208.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 158533 | 1 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
59.0¢ |
Change
0.010 ( 2.61 %) |
||||
| Open | High | Low | Volume | ||
| 57.5¢ | 59.0¢ | 57.0¢ | 35799 | ||
| Last updated 13.50pm 28/05/2024 ? | |||||
| RCE (ASX) Chart |